How much is Rapid Micro Biosystems worth in 2026?

Rapid Micro Biosystems has a current valuation of N/A based on their Later Stage VC (Series D1) round and secondary market data.

How much funding has Rapid Micro Biosystems raised?

Rapid Micro Biosystems has raised N/A in total funding across 1 funding rounds.

Rapid Micro Biosystems

Biotechnology

Rapid Micro Biosystems valuation and funding history | Last updated: March 16, 2021 | 1 funding rounds

Current Valuation

N/A

As of March 16, 2021

Total Funding Raised

N/A

Across 1 round

Last Round

Later Stage VC (Series D1)

$81.0M

Last Funding

Mar 2021

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
March 16, 2021	Later Stage VC (Series D1)	$81.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Rapid Micro Biosystems is currently valued at N/A as of March 16, 2021.

Track Rapid Micro Biosystems Valuation Updates

Get notified when Rapid Micro Biosystems raises new funding or valuation changes

Explore More Data

Detailed analysis for Rapid Micro Biosystems

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Rapid Micro Biosystems's valuation history, funding rounds, and growth metrics.

No credit card required

What is Rapid Micro Biosystems Worth in 2026?

Rapid Micro Biosystems is a leading private company in the Biotechnology sector. Track Rapid Micro Biosystems's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Rapid Micro Biosystems Valuation is Determined

Private company valuations like Rapid Micro Biosystems's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.